Data

Supplementary data-Intra-vaginal testosterone improves sexual satisfaction and vaginal symptoms associated with aromatase inhibitors. 2018.pdf

Monash University
Susan Davis (Aggregated by)
Viewed: [[ro.stat.viewed]] Cited: [[ro.stat.cited]] Accessed: [[ro.stat.accessed]]
ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Adc&rfr_id=info%3Asid%2FANDS&rft_id=info:doi10.26180/5b6517ab522f4&rft.title=Supplementary data-Intra-vaginal testosterone improves sexual satisfaction and vaginal symptoms associated with aromatase inhibitors. 2018.pdf&rft.identifier=http://doi.org/10.26180/5b6517ab522f4&rft.publisher=Monash University&rft.description=This table reports the clinician reported assessment outcomes for intra-vaginal testosterone vs placebo over 26 weeks in women taking an aromatase inhibitor&rft.creator=Susan Davis&rft.creator=Susan Davis&rft.date=2018&rft_rights=&rft_subject=testosterone&rft_subject=intra-vaginal&rft_subject=vulvo-vginal atrophy&rft_subject=breast cancer&rft.type=dataset&rft.language=English Access the data
Cite Saved to MyRDA Save to MyRDA

Licence & Rights:

Other view details
Cc-by 4.0

Full description

This table reports the clinician reported assessment outcomes for intra-vaginal testosterone vs placebo over 26 weeks in women taking an aromatase inhibitor

Issued: 2018-08-04

This dataset is part of a larger collection

Click to explore relationships graph
Help

Related People

Subjects
breast cancer | intra-vaginal | testosterone | vulvo-vginal atrophy |

User Contributed Tags    

Login to tag this record with meaningful keywords to make it easier to discover

Identifiers
ACN 633 798 857